AIMD Ainos Inc
1,239
$1.04
$0.00
(0.00%)
| Watchers | 1,239 |
| 52-Wk Low | $0.79 |
| 52-Wk High | $6.10 |
| Market Cap | $6.54M |
| Volume | 11,768.00 |
| 52-Wk High | $6.10 |
| 52-Wk Low | $0.79 |
Ainos, Inc. (NASDAQ:AIMD) Short Interest UpdateTicker Report • 2 months ago
Ainos, Inc. (NASDAQ:AIMD Get Free Report) was the target of a large drop in short interest in February. As of February 29th, there was short interest totalling 7,600 shares, a drop of 65.9...
Share to Feed
Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024Advancing VELDONA drug candidates to Phase III clinical studiesExpanding market of AI Nose-powered VOC-sensing...
Gagnants
Le titre Psyence Biomedical (NASDAQ:PBM) a grimp vendredi de 146,36% 3,13 dollars lors de la session ordinaire.
L'action Ainos (NASDAQ:AIMD) a grimp de 88,36% 2,11 dollars.
Le titre...
Titoli in rialzo
Il titolo Psyence Biomedical (NASDAQ:PBM) ha osservato un incremento del 140,94% a 3,06 dollari durante la sessione regolare di venerd .
Il titolo Ainos (NASDAQ:AIMD) ha avuto un...
Gagnants
Le titre Ainos (NASDAQ:AIMD) a grimp jeudi de 101,78% 2,26 dollars lors de la session after-market.
Le titre Immuron (NASDAQ:IMRN) a grimp de 36,26% 6,20 dollars.
L'action Talis...
Acciones al alza
Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes.
Ainos (NASDAQ:AIMD) experimentaron un...
Gagnants
Le titre Ainos (NASDAQ:AIMD) a mont vendredi de 54,28% 1,62 dollars lors de la session after-market.
Le titre Aadi Bioscience (NASDAQ:AADI) a grimp de 27,60% 2,45 dollars.
Le titre...
Updated Chemistry, Manufacturing, and Controls and Stability Test fulfill Ainos' development objectivesResolving the identified deficiencies will accelerate the timeline for Ainos' other clinical...
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comSAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE...
Ainos, Inc. (NASDAQ:AIMD Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 36,600...